Cells for Cells Competitors and Similar CompaniesClear all
Cells for Cells's competitors and similar companies include InGeneron, Sea4Us and Crinetics Pharmaceuticals.
 Cells for Cells Cells for Cells is a biotechnology company dedicated to the research, development, and commercialization of cellular therapies. |  InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. |  Sea4Us Sea4Us is a biopharmaceutical company focused on the discovery and development of pharmaceutical drugs based on marine compounds. |  Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. | |
Founding Date | Founding Date 2010 | Founding Date 2006 | Founding Date 2013 | Founding Date 2008 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Las Condes, CL HQ | Locations Houston, US HQ München, DE | Locations Budens, PT HQ | Locations San Diego, US HQ |
Employees | Employees 264% increase | Employees 16 | Employees 23 | Employees 43751% increase |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 47.5m | Total funding raised N/A | Total funding raised $ 41.5m |
For sources of this data, please see the company profile
View Company Profiles
InGeneron
HQ
Houston, US
Employees
16
InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.
View companySea4Us
HQ
Budens, PT
Employees
23
Sea4Us is a biopharmaceutical company focused on the discovery and development of pharmaceutical drugs based on marine compounds.
View companyCrinetics Pharmaceuticals
HQ
San Diego, US
Employees
437
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View company